|Brand name(s), other common name(s)||Oncaspar®, PEG-L-asparaginase|
|Drug type||Enzyme that prevents cancer cells from surviving|
|How the drug is given||Intravenously (IV)|
Pegaspargase is FDA approved in combination with other chemotherapy medications to treat people who have acute lymphoblastic leukemia (ALL).
Side effects needing medical attention:Abdominal or stomach pain; blurry vision; constipation; dry mouth and skin; fatigue; increased hunger or thirst; increased need to urinate; nausea; rash; unexplained weight loss; vomiting.